Patents by Inventor Armando Cedro

Armando Cedro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents and compositions thereof for the hair treatment
    Patent number: 6232302
    Abstract: Compositions containing depolymerized fucane sulphates characterized by the following parameters (percentages by weight on the dry product): Molecular weight: 5,000-30,000 dalton; Sulphur: 5-16%; Fucose: 25-60%; Uronic acids 2-25%; they increase the percentage of growing hair and inhibit the Pytirosporun growth on the skin.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: May 15, 2001
    Assignee: Crinos Industria Farmacobiologica S.p.A.
    Inventors: Pia Alberico, Armando Cedro, Danilo Moltrasio, Roberto Porta
  • Fucans with low molecular weight having anticoagulant, antithrombinic and antithromobic activity
    Patent number: 5948405
    Abstract: Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity.Fucan sulfates having molecular weight between 14000 and 29000 Dalton show a remarkable anticoagulant activity both in the global coagulation mechanism (APTT) and in the last phase of coagulation (antithrombinic activity). These compounds are useful also as antithrombotic drugs.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: September 7, 1999
    Assignee: Crinos Industria Farmacobiologica S.p.A.
    Inventors: Armando Cedro, Roberto Porta, Franco Cattaneo, Fabio Trento, Laura Ferro, Ennio Lanzarotti
  • Process producing lower molecular weight range oligodeoxyribonucleotides
    Patent number: 5646268
    Abstract: The invention discloses new oligodeoxyribonucleotides of animal origin, having a molecular weight comprised between 4000 and 10000 daltons, that can be obtained by fractionation of polydeoxyribonucleotides or otherwise by chemical or enzymatic depolymerization of high molecular weight deoxyribonucleic acids. The new compounds are endowed with a significant anti-ischemic activity.
    Type: Grant
    Filed: January 31, 1996
    Date of Patent: July 8, 1997
    Assignee: Crinos Industria Farmacobiologica S.p.A.
    Inventors: Ennio Lanzarotti, Marisa Mantovani, Giuseppe Prino, Roberto Porta, Armando Cedro, Danilo Moltrasio
  • Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alpha-cyclodextrin and related intermediate compound
    Patent number: 5152998
    Abstract: By ultrafiltration of an aqueous solution wherein there have been formerly dissolved alfa-cyclodextrin and a raw lipidic mixture, the latter characterized in that it contains monosialoganglioside (GMl) either as the sole ganglioside or otherwise in a prevailing quantity over the other associated gangliosides, and after the removal of cyclodextrin at the end of the process, it is obtained GMl with a titer of at least 95%. The present invention concerns also the intermediate complex that it is being formed between the hereabove said monosialoganglioside and alfa-cyclodextrin.
    Type: Grant
    Filed: February 12, 1992
    Date of Patent: October 6, 1992
    Assignee: Crinos Industria Farmacobiologica SpA
    Inventors: Benito Casu, Ennio Lanzarotti, Giangiacomo Torri, Annamaria Naggi, Armando Cedro
  • Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alfa-cyclodextrin and related intermediate compound
    Patent number: 5108613
    Abstract: By ultrafiltration of an aqueous solution wherein there have been formerly dissolved alfa-cyclodextrin and a raw lipidic mixture, the latter characterized in that it contains monosialoganglioside (GM1) either as the sole ganglioside or otherwise in a prevailing quantity over the other associated gangliosides, and after the removal of cyclodextrin at the end of the process, it is obtained GM1 with a titer of at least 95%. The present invention concerns also the intermediate complex that it is being formed between the hereabove said monosialoganglioside and alfa-cyclodextrin.
    Type: Grant
    Filed: July 15, 1991
    Date of Patent: April 28, 1992
    Assignee: Crinos Industria Farmacobiologica S.p.A.
    Inventors: Benito Casu, Ennio Lanzarotti, Giangiacomo Torri, Annamaria Naggi, Armando Cedro
  • Peptides correlated to lysozyme
    Patent number: 4784988
    Abstract: A peptide made up of at least 3 amino acids comprised in sequential form in the following structure: ##STR1## where Y may be absent or represent a glycine residue, where the amino acids ##STR2## represent the sequences between positions 39-45 and 46-53 of hen egg-white lysozyme.
    Type: Grant
    Filed: December 11, 1986
    Date of Patent: November 15, 1988
    Assignee: Spa Societa' Prodotti Antibiotici S.p.A.
    Inventors: Tiberio Bruzzese, Armando Cedro, Holger H. Van Den Heuvel